The crystal structure of a 310 helical decapeptide containing α-aminoisobutyric acid  by Francis, A.K. et al.
Volume 155, number 2 FEBS LETTERS May 1983 
The crystal structure of a 3 10 helical decapeptide containing cy- 
aminoisobutyric acid 
AK Francis, M. Iqbal, P. Balaram and M. Vijayan 
Molecular Biophysics Unit, Indian Institute of Science, Bangalore 560 012, India 
Received 9 March 1983 
Abstract not received 
Channel forming ionophores Decapeptide c~-Aminoisobutyric acid 
X-ray structure analysis 310 helix 
1. INTRODUCTION 
Alamethicin and several related a- 
aminoisobutyric acid (Aib) containing natural and 
synthetic peptides form voltage-dependent chan- 
nels across lipid bilayer membranes [1,2]. Their 
high Aib content constrains these peptides to adopt 
310 [2,3] or a-helical conformations [1,4]. Mem- 
brane channels are then formed by helical peptide 
aggregation in the lipid phase [l-3,5], with a ma- 
jor role for the macrodipole moment of the peptide 
helices in mediating monomer association and 
channel characteristics [2,6]. The precise helical 
conformation (3i0 or cu) of Aib peptides is of in- 
terest since spatial disposition of side chains are 
different in the two cases and may lead to 
significantly different modes of association. This 
may be relevant in developing detailed molecular 
models for peptide channels. While 310 helical 
structures have been observed, except in one case 
[7], for short Aib containing peptides [2,3,8-lo], 
an 1 l-residue model peptide [11,12] and the 
20-residue natural product alamethicin [ 131 have 
been shown to adopt a-helical structures in the 
solid state. These results have been interpreted as 
implying that 310 helices are supported only in very 
short sequences [4,12]. 
We describe here the solid state conformation of 
the lo-residue peptide: 
Boc-Aib-Pro-Val-Aib-Val-Ala-Aib-Ala-Aib-Aib-OMe 
which adopts a 310 helical structure. This result 
suggests that chain length may not be an overriding 
criterion in determining the mode of helical folding 
in these peptides. 
2. MATERIALS AND METHODS 
The decapeptide, synthesized by solution phase 
procedures used earlier for alamethicin I [14], was 
crystallized from a methanol-dimethylsulfoxide 
mixture. The crystals are orthorhombic, space 
group P2i2121, with 4 molecules in a unit cell of 
dimensions a = 8.894(2), b = 15.577(3) and c = 
41.810(7) A. The X-ray intensity data were col- 
lected on a computer controlled CAD-4 diffrac- 
tometer, employing (J - 28 scan using graphite 
monochromated copper radiation up to a Bragg 
angle of 60”. The structure was solved by a com- 
bination of the vector search methods [15] and the 
direct methods using the MULTAN program [ 161. 
The atomic parameters were refined by the struc- 
ture factor least squares method to an R factor of 
0.096 for 3374 observed reflections. The details of 
the X-ray analysis will be presented elsewhere. 
3. RESULTS AND DISCUSSION 
A perspective view of the decapeptide is shown 
in fig. 1. The torsion angles which define the main 
chain conformation [17] are given in table 1. The 
intramolecular hydrogen-bond parameters are 
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Fig. 1. A perspective view of the decapeptide molecule. 
Table 1 
Main chain conformational ngles (“) in the decapeptide 
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Table 2 
hydrogen bond parameters in the 
decapeptide 
Aib 
Pro 
Val 
Aib 
Val 
Ala 
Aib 
Ala 
Aib 
Aib 
4 Ic w 
-53 -35 - 176 
-59 -27 - 179 
-70 - 16 -178 
-53 -34 -176 
-64 -12 175 
-61 - 16 171 
-50 -33 - 177 
-65 -20 176 
-63 -24 - 179 
50 4oa -176a 
a + and (J for the C-terminal residue are defined by 
assuming that the methoxyl oxygen is stereochemically 
equivalent to a peptide nitrogen atom 
Hydrogen bond N-_-O H-N-_-O 
(A) (“) 
Boc CO---HN Val(3) 3.19 9 
Aib(1) CO---HN Aib(4) 3.00 15 
Val(3) CO- - - HN Ala(6) 3.02 4 
Aib(4) CO - - -HN Aib(7) 3.13 0 
Val(5) CO- - -HN Ala(8) 2.94 9 
Ala(6) CO- - -HN Aib(9) 3.00 19 
Aib(7) CO---HN Aib(l0) 3.11 12 
listed in table 2. The molecule assumes a nearly 
regular right-handed 310 helical conformation, 
with 4,# values close to their ideal values of 4 = 
- 60”, 3 = - 30“. All the intramolecular 4- 1 
hydrogen bonds appropriate for a 310 helix are 
formed, with one exception. The NH group of 
Val(5) is directed towards the CO group of Pro(2) 
but the observed N- - -0 separation of 3.46 A is 
rather large for a good hydrogen bond. 
We have determined the crystal structure of the 
amino (residues 1-5) and carboxy (residues 6-10) 
terminal pentapeptide fragments of the decapep- 
tide. The l-5 pentapeptide [7] assumes a 4-fold 
helical conformation, whereas the 6-10 fragment 
is an almost perfect 310 helix [10,18]. However, in 
the decapeptide an almost uniform 310 helix is 
observed over the entire length, although some 
distortion exists in the amino-terminal half, on ac- 
count of the increased separation of the Pro(Z) CO 
and Val(5) NH groups. A 310 helical conformation 
with 8 intramolecular N-H - - - 0 hydrogen 
bonds, 7 strong and 1 weak, has been established 
in CDCl3 and (CD&SO solutions for this decapep- 
tide, from ‘H NMR studies [ 191. The solid state 
structure is thus in general agreement with the 
postulated structure in solution. 
The decapeptide, whose structure has been 
described above, corresponds to the amino- 
terminal sequence originally proposed for the 
channel forming polypeptide, suzukacillin A [20]. 
Subsequently this sequence has been revised, by 
deleting the 2-5 segment of the decapeptide, 
-Pro-Val-Aib-Val- (G. Jung, personal com- 
munication). Nevertheless, the fact that the 
decapeptide folds into a 310 helix despite the 
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presence of 2 Val residues, which have a low 
preference for helical conformations [21], 
demonstrates the high propensity of Aib residues 
to dictate helical folding. This study also 
establishes that 310 helical conformations may be 
favoured even in relatively large oligopeptides, 
contrary to earlier suggestions that only a-helical 
structures are likely to be adopted in peptides 
longer than 5-6 residues 14,121. However, as men- 
tioned earlier, an 1 l-residue Aib-containing pep- 
tide [ 11,121 and the 20-residue peptide alamethicin 
[13] fold into cr-helices. It would therefore appear 
that the difference between the propensities of Aib 
residues for promoting 310 and cr-helical conforma- 
tions in peptides, is marginal. The effect of the 
proportion and precise positioning of Aib in a 
given peptide, the role of peptide-peptide interac- 
tions and the influence of solvent in the choice bet- 
ween 31~ and cu-heiices are, however, yet to be 
established. 
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